Vessela Vassileva
Vessela Vassileva
Senior Research Associate, UCL
Verified email at
Cited by
Cited by
Interleukin-6 as a therapeutic target in human ovarian cancer
J Coward, H Kulbe, P Chakravarty, D Leader, V Vassileva, DA Leinster, ...
Clinical cancer research 17 (18), 6083-6096, 2011
Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC)
JPM Nunes, M Morais, V Vassileva, E Robinson, VS Rajkumar, ...
Chemical Communications 51 (53), 10624-10627, 2015
Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability
V Vassileva, A Millar, L Briollais, W Chapman, B Bapat
Cancer research 62 (14), 4095-4099, 2002
Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice
G Hartmann, V Vassileva, M Piquette-Miller
Drug Metabolism and Disposition 33 (6), 820-828, 2005
Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer
V Vassileva, CJ Allen, M Piquette-Miller
Molecular Cancer Therapeutics 7 (3), 630-637, 2008
Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody
E Robinson, JPM Nunes, V Vassileva, A Maruani, JCF Nogueira, ...
RSC advances 7 (15), 9073-9077, 2017
In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel
EA Ho, V Vassileva, C Allen, M Piquette-Miller
Journal of controlled release 104 (1), 181-191, 2005
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model
V Vassileva, J Grant, R De Souza, C Allen, M Piquette-Miller
Cancer chemotherapy and pharmacology 60, 907-914, 2007
Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging
V Vassileva, EH Moriyama, R De Souza, J Grant, CJ Allen, BC Wilson, ...
British journal of cancer 99 (12), 2037-2043, 2008
Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC)
JPM Nunes, V Vassileva, E Robinson, M Morais, MEB Smith, RB Pedley, ...
RSC advances 7 (40), 24828-24832, 2017
Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
PJT Reardon, M Parhizkar, AH Harker, RJ Browning, V Vassileva, ...
International journal of nanomedicine, 3913-3926, 2017
Targeting pyruvate kinase M2 and lactate dehydrogenase A is an effective combination strategy for the treatment of pancreatic cancer
GH Mohammad, V Vassileva, P Acedo, SWM Olde Damink, M Malago, ...
Cancers 11 (9), 1372, 2019
Tunable semiconducting polymer nanoparticles with INDT-based conjugated polymers for photoacoustic molecular imaging
T Stahl, R Bofinger, I Lam, KJ Fallon, P Johnson, O Ogunlade, ...
Bioconjugate Chemistry 28 (6), 1734-1740, 2017
Inflammation: Extinguishing the fires within
V Vassileva, M Piquette‐Miller
Clinical Pharmacology & Therapeutics 87 (4), 375-379, 2010
Significant therapeutic efficacy with combined radioimmunotherapy and cetuximab in preclinical models of colorectal cancer
V Vassileva, V Rajkumar, M Mazzantini, M Robson, A Badar, S Sharma, ...
Journal of Nuclear Medicine 56 (8), 1239-1245, 2015
Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients
V Vassileva, A Millar, L Briollais, W Chapman, B Bapat
Oncology reports 11 (4), 931-937, 2004
Inflammation: the dynamic force of health and disease
V Vassileva, M Piquette‐Miller
Clinical Pharmacology & Therapeutics 96 (4), 401-405, 2014
Evaluation of apoptosis imaging biomarkers in a genetic model of cell death
V Vassileva, SM Stribbling, C Barnes, L Carroll, M Braga, J Abrahams, ...
EJNMMI research 9, 1-13, 2019
The significance of some prognostic factors on local tumor control in early breast cancer after conservative surgery and radiotherapy
L Marinova, J Todorov, I Koleva, V Vassileva
Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging
V Vassileva, M Braga, C Barnes, J Przystal, A Ashek, L Allott, D Brickute, ...
Biomedicines 9 (7), 811, 2021
The system can't perform the operation now. Try again later.
Articles 1–20